Accelerated Approval of New TKI Use in CML Sparks Questions

Source link : https://www.yourblogdomain.com/2024/12/02/accelerated-approval-of-new-tki-use-in-cml-sparks-questions/

Source link : https://www.newshealth.biz/health-news/accelerated-approval-of-new-tki-use-in-cml-sparks-questions/ US regulators’ use of a speedy clearance pathway for a new frontline indication for asciminib for chronic myeloid leukemia (CML) has raised questions due to the number of medications already available for this condition. In October, the US Food and Drug Administration (FDA) granted accelerated approval to asciminib (Scemblix, Novartis AG) […]

Author : yourblogdomain

Publish date : 2024-12-02 11:34:56

Copyright for syndicated content belongs to the linked Source.